Anagrelide Capsule
Product Images NDC 70954-879

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Anagrelide (NDC 70954-879). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Ani Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Graph (Graph)

Graph (Graph)
Patients with Thrombocytosis Secondary to Myeloproliferative Disorders were monitored for Mean Platelet Count during Anagrelide Therapy over 208 weeks. The chart shows the platelet count fluctuating between 1200 and 2900. The number of subjects ranged from 923 at the start to 55 by the end of the treatment period.*
FDA Label Image

Label-1 (Label 1)

Label-1 (Label 1)
This text is a description of Anagrelide capsules, a platelet-reducing agent. It includes information on dosage and administration, storage conditions, manufacturer details, and distribution information. The capsules contain 0.5 mg of anagrelide base and are recommended to be taken up to 4 times daily, not exceeding a total daily dose of 10 mg. The medication should be kept out of reach of children and stored in specific conditions. Manufacturing and distribution details are also provided in the text.*
FDA Label Image

Label-2 (Label 2)

Label-2 (Label 2)
This text describes a medication called Anagrelide in capsule form, which is a platelet-reducing agent. It provides details on the dosage and administration instructions, stating that each capsule contains 1 mg of anagrelide base. The starting dose is 1 capsule up to 2 times daily, with a maximum daily dose of 10 mg. The medication should be stored at 20°C to 25°C and kept out of reach of children. It also includes information about the manufacturer and distributor of the medication.*
FDA Label Image

Structure (Structure)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.